KK
AUPH icon

KLP Kapitalforvaltning’s Aurinia Pharmaceuticals AUPH Stock Holding History

KLP Kapitalforvaltning’s Portfolio AUPH Stock Details AUPH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$747K Hold
44,000
– – ﹤0.01% 1296
2026
Q1 		$652K Buy
44,000
+2,300
+6% +$33.6K ﹤0.01% 1280
2025
Q4 		$665K Buy
41,700
+19,300
+86% +$274K ﹤0.01% 1265
2025
Q3 		$248K Hold
22,400
– – ﹤0.01% 1732
2025
Q2 		$190K Hold
22,400
– – ﹤0.01% 1807
2025
Q1 		$180K Hold
22,400
– – ﹤0.01% 1794
2024
Q4 		$201K Buy
+22,400
New +$183K ﹤0.01% 1819

Other funds holding AUPH

TCM
Tang Capital Management San Diego, California $2.2B AUM 156.35% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
NMC
NEA Management Company Timonium, Maryland $1.59B AUM 234.06% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $225B AUM 49.49% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

KLP Kapitalforvaltning's AUPH Position: Q2 2026 in Review

KLP Kapitalforvaltning held its Aurinia Pharmaceuticals (AUPH) position steady in Q2 2026 at 44,000 shares worth $747K. The position accounts for ﹤0.01% of the portfolio, ranked #1296.

KLP Kapitalforvaltning first reported a position in AUPH in Q4 2024 and has held it in 7 quarters since. 282 funds tracked by Wall St. Rank hold AUPH as of Q2 2026.

  • KLP Kapitalforvaltning held 44,000 shares of Aurinia Pharmaceuticals worth $747K as of Q2 2026.
  • KLP Kapitalforvaltning left its Aurinia Pharmaceuticals share count unchanged in Q2 2026.
  • Aurinia Pharmaceuticals made up ﹤0.01% of KLP Kapitalforvaltning's portfolio in Q2 2026, its #1296 holding.
  • KLP Kapitalforvaltning first reported a position in Aurinia Pharmaceuticals in Q4 2024 and has held it in 7 quarters since.
  • 282 funds tracked by Wall St. Rank held Aurinia Pharmaceuticals as of Q2 2026.

Based on KLP Kapitalforvaltning's 13F filing for Q2 2026, filed 12 Aug 2026.